Top compounds associated with response to EFHB


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.032 0.3
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.034 0.3
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.054 0.3
mRNA foretinib GDSC1000 pan-cancer AAC 0.034 0.3
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.036 0.3
mRNA Mitomycin-C GDSC1000 pan-cancer AAC 0.036 0.3
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.037 0.3
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.028 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
Download CSV